Get Protocol Title Type I Diabetes Trialnet Protocol Tn-10, Anti-cd3 Mab (teplizumab) For Prevention Of

Filling out the Protocol Title Type I Diabetes TrialNet Protocol TN-10, Anti-CD3 MAb (Teplizumab) for Prevention of form online is an important step for participants in the study. This guide will help you complete the form accurately and efficiently.

Follow the steps to accurately complete your Protocol Title form online.

1. Click ‘Get Form’ button to obtain the form and open it in the editor.
2. Review the protocol title carefully and ensure it matches the provided title: Type I Diabetes TrialNet Protocol TN-10, Anti-CD3 MAb (Teplizumab) for Prevention of Diabetes in Relatives At-Risk for Type 1 Diabetes Mellitus.
3. Specify whether you are an adult participant or a parent/guardian providing consent for a child by checking the appropriate box.
4. If you are a parent or guardian, print the child’s name clearly in the designated area.
5. Indicate if you are participating in any other research studies by selecting 'Yes' or 'No.'
6. Read through the introduction to the research studies section and ensure you understand the difference between being a patient and a research participant.
7. Review the purpose of the research, ensuring you comprehend the objectives and process of the trial involving teplizumab.
8. Confirm your understanding of the study duration, which is expected to last approximately 4-6 years, and that your participation is voluntary.
9. Acknowledge your responsibilities as a participant by reviewing the bullet points and ensuring you can comply with them.
10. Finally, provide your signature and date on the form to confirm your consent. Make sure to keep a copy for your records.

Don't wait! Start filling out your Protocol Title form online today.